DHA from algae and DHA from fish are the same molecule. The products that deliver them are not the same product. The contamination profile, the oxidation rate, the bioavailability, and the regulatory standing all differ, and the EU has been quietly migrating its infant formula supply to algal DHA since 2020.
what to know in three lines.
DHA (docosahexaenoic acid) is a long-chain omega-3 fatty acid. It is a structural component of the human brain and retina, not a nutritional add-on. Roughly 15% of all fatty acids in the human frontal cortex are DHA, and during the third trimester of pregnancy and the first two years of life, an infant brain is incorporating DHA at a rate it will never match again.
Every infant formula sold in the EU has been required by law to contain DHA since February 2020, at 20–50 mg per 100 kcal, under Commission Delegated Regulation 2016/127. In the US, DHA is permitted but not federally mandated. The question is no longer whether babies should receive DHA. The question is where it comes from.
three sources, one molecule, different supply chains.
Microalgae (Schizochytrium sp., Crypthecodinium cohnii) produce DHA directly. Grown in sealed stainless steel fermenters on a sterile sugar substrate. Never contact seawater.
Extracted from oily fish: anchovy, sardine, menhaden. Fish do not produce DHA. They accumulate it from algae they eat, alongside whatever else is in the ocean.
A processing pathway, not a source. Hexane is used to extract DHA from algae or fish more cheaply. Permitted in US formula. Prohibited under EU organic certification.
Fish do not synthesise DHA. They eat algae. The omega-3 fatty acids in salmon, mackerel, anchovy, and sardine begin in microalgae at the base of the food chain and accumulate as they move up. So do mercury, polychlorinated biphenyls (PCBs), dioxins, and microplastics. DHA and contaminants travel together.
Algae sit one full step below this. Cultivated algae do not encounter any of those contaminants because they never enter the ocean. The DHA molecule produced is identical. The product around the molecule is not.
You have probably read the word “DHA” on a formula tin or supplement bottle and felt vaguely reassured. That is what the label was designed to do. The problem is that “DHA” tells you almost nothing. It is a molecule, not a product. And the difference between the products on the shelf is the difference between an oil that is structurally identical to what is in breast milk and one that has been processed through a contaminated supply chain to get there.
how it is made, and why it matters.
Algal DHA is produced by growing microalgae, typically Schizochytrium sp. or Crypthecodinium cohnii, in closed stainless steel fermenters. The algae are fed a sterile sugar substrate. The DHA is extracted from the algae as a triglyceride and bottled. There is no fish, no ocean, no concentration step.
This matters because the contamination profile of fish oil is a function of the marine environment. Mercury, PCBs, and dioxins exist in fish because they exist in seawater. An organism cultivated in a sealed tank on land has no plausible exposure route to any of them.
The European Food Safety Authority assessed Schizochytrium sp. (strain CABIO-A-2) oil for use in infant and follow-on formula in 2023. DHA represented 38–44% of total fatty acids in triglyceride form. A 90-day repeated-dose toxicity study in rats found no adverse effects up to 10.2 g per kg body weight per day, the highest dose tested. Heavy metals were below limits of quantification. The Panel concluded the oil was safe at proposed use levels with no contamination concerns. EFSA scientific opinion (2023).
Arrives in natural triglyceride form. Three fatty acids attached to a glycerol backbone, the same form found in human breast milk. The infant gut is built to absorb it. No conversion or re-esterification step is required.
Carries no marine contamination. Mercury, PCBs, dioxins, and microplastics all enter the supply chain through the ocean. Closed-system cultivation removes that pathway entirely.
Bioequivalent to fish-derived DHA in infants. A 2017 randomised double-blind controlled trial in 159 healthy term infants (NCT02132663) found red blood cell DHA incorporation between two algal sources fell within the 80–125% bioequivalence window (90% CI: 91–104%). Growth, tolerance, and DHA delivery were equivalent across sources.
Algal DHA appears as “DHA from Schizochytrium oil,” “DHA from Crypthecodinium cohnii,” “algal oil,” or “algae-derived DHA.” It is the DHA source used in every EU-certified organic infant formula on the market: HiPP, Holle, Kendamil, Jovie, Löwenzahn, Pure Goat. It also appears in higher-quality US infant DHA supplements.
two compounding issues, neither resolved by processing.
Fish oil DHA is extracted from the tissues of oily marine fish. The raw oil is then refined, deodorised, and frequently concentrated to raise the DHA percentage. The refining step exists because raw fish oil is not clean. The concentration step exists because raw fish oil is only about 30% DHA plus EPA combined.
Both steps create problems.
Bourdon et al. (2010) in Food and Chemical Toxicology tested 17 omega-3 supplements available in Canada. PCB concentrations ranged from below detection to 793 ng per gram of oil. Salmon- and seal-derived products yielded the highest values. A 2013 follow-up in the Journal of Food Science tested 13 over-the-counter children’s fish oil supplements and found every supplement contained PCBs, with mean daily exposures of 2.5–50.3 ng per day at label serving sizes.
DHA has six double bonds in its molecular structure. Each one is a site where oxygen, heat, and light can degrade the molecule. By the time a fish oil supplement reaches a consumer it has been extracted from raw tissue, refined, deodorised, frequently re-esterified, encapsulated, shipped, and shelved. Every step is an opportunity for oxidation. The data on how often this goes wrong is consistent across countries.
Albert et al. (2015) in Scientific Reports tested all encapsulated fish oil supplements marketed in New Zealand. 83% exceeded the recommended peroxide value limit. 50% exceeded the total oxidation (TOTOX) limit. A 2015 review in the Journal of Nutritional Science reported similar findings across multiple countries: 50% of 171 Canadian supplements failed, 27% of US products had over twice the recommended lipid peroxide levels, and over 80% of South African and New Zealand products failed. A 2023 multi-year US analysis of 72 omega-3 supplements found 68% of flavoured products and 13% of unflavoured products exceeded GOED TOTOX limits.
Oxidised omega-3 fatty acids are not simply less effective. The breakdown products, aldehydes, ketones, and lipid peroxides, have been shown in animal models to reduce antioxidant capacity and induce oxidative stress, even while the oil still measurably lowers triglycerides. A supplement can deliver some DHA and a measurable dose of oxidative stress at the same time. Flavouring is often used to mask rancidity already underway.
the second question that is rarely on the label.
Beyond source, there is a second question that is rarely addressed on a label: what chemical form is the DHA in. This affects how much of the DHA on the bottle ends up in the bloodstream.
Natural fish oil contains DHA in triglyceride form: three fatty acids attached to a glycerol backbone. This is the form found in human breast milk. The infant gut is built to absorb it. When fish oil is concentrated to raise DHA potency above the natural ~30% combined DHA+EPA, the triglycerides are typically broken apart and converted to ethyl ester form. Ethyl esters are cheaper to produce and more shelf-stable. They are also significantly less bioavailable.
Some manufacturers then re-esterify the ethyl esters back into triglycerides (rTG form) at additional cost. Each conversion step degrades the molecule further from its natural state. Algal DHA is produced directly as a triglyceride and stays that way. There is no concentration step, no conversion, no need to reverse-engineer the natural structure.
Neubronner et al. (2011) in the European Journal of Clinical Nutrition. After six months of supplementation, the omega-3 index increased significantly more in subjects taking re-esterified triglycerides (8.4% to 11.3%) than in subjects taking ethyl esters (8.1% to 10.3%). The difference was apparent at three months and significant at six. For an infant in the period of fastest DHA accretion, the difference between forms compounds quickly.
Triglyceride form (good): “DHA in triglyceride form,” “natural triglyceride DHA,” or “rTG.”
Ethyl ester (lower bioavailability): “DHA ethyl ester,” or no form stated at all on a concentrated fish oil. If form is unstated and the product is a high-concentrate fish oil, ethyl ester is the default.
Algal DHA: always triglyceride form by default. No conversion happens upstream.
the rows the labels do not give you.
the EFSA standard, in numbers.
The European Food Safety Authority recommends 100 mg of DHA per day for infants and young children up to 24 months of age. EU infant formula must contain DHA at 20–50 mg per 100 kcal, which delivers that 100 mg target at typical formula intakes without further supplementation.
For breastfed babies, DHA in milk reflects the mother’s diet directly. Maternal supplementation increases milk DHA in a near-linear fashion. Breastfeeding mothers are advised to consume 200–300 mg of DHA daily from oily fish, algal supplements, or DHA-fortified foods. After age two, EFSA’s recommendation steps up to 250 mg daily through age 18.
Most healthy, full-term infants on either breast milk from a DHA-replete mother or an EU-certified organic formula do not need a separate DHA supplement. The DHA is already there. Supplementation enters the picture in four specific situations.
The breastfeeding mother eats little to no fish. If oily fish does not appear in the diet at least twice a week and no DHA supplement is taken, milk DHA will fall below recommended levels. The simplest correction is to supplement the mother, not the infant.
The family follows a vegetarian or vegan diet. Plant ALA from flax, chia, and walnuts converts to DHA at roughly 1–9%. That conversion rate is not sufficient during early life. An algal DHA supplement closes the gap without compromising dietary values.
The formula does not contain DHA at meaningful levels. Rare in the EU, increasingly rare in the US, but check the panel. If DHA is absent, supplementation is appropriate.
Premature birth or low birth weight. Premature infants miss part or all of the third-trimester DHA accumulation window. Post-mortem analyses have confirmed lower cortical DHA concentrations in preterm-born infants compared to term-born. Supplementation in this group is managed by a paediatrician or neonatologist, not self-prescribed.
the markers that separate a clean product from the rest.
“Algal DHA,” “algae oil,” or a named strain (Schizochytrium sp. or Crypthecodinium cohnii). If the label says only “fish oil” or “marine oil” without further specification, treat it as a generic refined fish oil with the contamination and oxidation risks documented above.
The label should state triglyceride form or natural triglyceride. If unstated and the product is fish-derived, ethyl ester is the default.
Algal DHA is suspended in a carrier oil. Look for organic olive oil or organic sunflower oil. Avoid generic “vegetable oil” (often a blend including soybean), GMO palm oil, and any product that lists no carrier oil at all.
Mixed tocopherols (vitamin E) prevent oxidation of the DHA itself. Their presence is a quality marker, not a red flag.
Artificial flavours, sweeteners, sugar, “natural flavor” without specification, citric acid as a primary preservative, soybean oil, or marine sources that do not name the species. Heavy flavouring is itself a warning, given the 2023 finding that 68% of flavoured omega-3 supplements failed TOTOX limits versus 13% of unflavoured. Flavour masks oxidation.
Glass dropper bottle, ideally amber or dark-tinted to block light degradation. Plastic increases oxidation risk. Look for explicit third-party testing for heavy metals, PCBs, and oxidation markers (peroxide and anisidine values). Reputable algal DHA producers publish these openly. The values for algal DHA are routinely orders of magnitude lower than fish oil equivalents.
the practical decision, in two columns.
If a formula or supplement says “contains DHA” and you want to know whether it is a clean product, look for algal DHA specifically, in triglyceride form, in a glass dropper bottle, with mixed tocopherols and a named species or strain on the label. That is the version with the contamination-free supply chain, the natural triglyceride structure, the EU regulatory standing, and the randomised infant trial behind it.
This article is research and educational content. It is not medical advice. Discuss any supplementation decision for your infant with a paediatrician.